B. Metzler Seel. Sohn & Co. Ag Astrazeneca PLC Transaction History

B. Metzler Seel. Sohn & Co. Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $191,277 - $231,416	-2,863 Reduced 25.99%	8,154 $635,000
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $379,789 - $432,934	-6,223 Reduced 36.1%	11,017 $746,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $71,854 - $80,434	-1,161 Reduced 6.31%	17,240 $1.16 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $229,958 - $254,248	-3,546 Reduced 16.16%	18,401 $1.25 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $265,518 - $287,926	-3,798 Reduced 14.75%	21,947 $1.57 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $103,881 - $117,781	-1,645 Reduced 6.01%	25,745 $1.79 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $89,338 - $116,085	-1,648 Reduced 5.68%	27,390 $1.86 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $20,730 - $53,078	391 Added 1.36%	29,038 $1.59 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $137,186 - $164,689	-2,315 Reduced 7.48%	28,647 $1.89 Million
Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $253,526 - $305,396	-4,550 Reduced 12.81%	30,962 $2.05 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $1.92 Million - $2.27 Million	35,512 New	35,512 $2.08 Million

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.